西安利君

Xi'an Lijun Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical manufacturer with a history dating back to 1938. Headquartered in Xi'an, the company specializes in the research, development, and production of finished medicines and active pharmaceutical ingredients (APIs), with a core focus on antibiotics and traditional Chinese medicine (TCM). Its flagship product, Lijunsha (Erythromycin Ethylsuccinate), has been a market leader in China's macrolide antibiotic sector for decades. The company operates large-scale, GMP-certified manufacturing facilities producing a wide range of dosage forms, including tablets, capsules, and injections. Xi'an Lijun serves both domestic and international markets, maintaining a strong reputation for quality in the anti-infective and respiratory therapeutic areas.